Baseline comorbidity of cardiovascular-kidney-metabolic syndrome increases the risk of adverse clinical outcomes in patients with chronic kidney disease
Our research demonstrated that a high-risk CKM stage can predict adverse clinical outcomes in CKD patients, including all-cause mortality and progression to ESRD.
Authors
- Aihua Zhang (ORCID: https://orcid.org/0000-0003-4044-9227)
- Wen Li (ORCID: https://orcid.org/0009-0008-3930-6302)
- Wenjing Fu
- Jiali Meng
Institutions
- Capital Medical University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3389/fendo.2025.1563164
- Citations
- 4
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 5.72